I am a healthcare professional

Notice

Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.

Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.

By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.

Cookies

We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.

You can find out more about cookies by browsing our Privacy Policy.

I am a healthcare professional in the United States

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Roche and Genentech at

ECTRIMS 2025

September 24 - September 26

Barcelona, Spain / Virtual (Hybrid)

ectrims.eu

We will be contributing to topics related to

Neuroscience

Agenda

Medical Materials

06:30 AM

Duration 120mins Barcelona, Spain

Characteristics of Patients Starting Ocrelizumab Subcutaneous in Denmark, Germany, and the United Kingdom

Braune, Stefan; Ingram, Gillian; Sellebjerg, Finn; Christensen, Jeppe Romme; Rasmussen, Peter Vestergaard; Jensen, Henrik Boye; Prakash, Sivagini; Bergmann, Arnfin; Witts, James A; Pearson, Owen; Middleton, Rod; Jarecki, Jana B; Heer, Yanic; Ferro, Ana; Acosta, Juan; Magyari, Melinda

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

Symptoms related to lower and upper limb function frequently impact daily activities in people with multiple sclerosis

Mclver, Tammy; Davies, Evan; Galactionova, Katya; Fisher, Kathryn; Dolan, Chantal; Durand-Zaleski, Isabelle; Clinch, Susanne

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

A 20% change in the Timed 25-Foot Walk Test and 9-Hole Peg Test is clinically meaningful

Mclver, Tammy; Galactionova, Katya; Fisher, Kathryn; Dolan, Chantal; Tumani, Hayrettin; Mantovani, Lorenzo; Davies, Evan

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

Associations Between Comorbidities, Disease Activity and Response to Ocrelizumab in the CHIMES Trial

Reder, Anthony; Wu, Gregory; Okai, Annette; Chinea, Angel; Sokhi, Dilraj Singh; Williams, Mitzi; Vartanian, Tim; Bernitsas, Evanthia; Monson, Nancy; Khatri, Bhupendra; Amjad, Faria; Goldstick, Lawrence; Jones, David: Pei, Jinglan; Clayton, David; Smith, Jugena; Abioye, Ibraheem; Amezcua, Lilyana

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

Understanding the Experiences of Neurologists Treating Women with MS and their Perspectives about Family Planning with MS in Europe and the United States

Seetasith, Arpamas; Pasquarelli, Noemi; Muros, Erwan; Johnson, Will; Unsworth, Mia; Pineda, Elmor D.

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

Integrating multicentre data to explore rwPIRA: Results from the INTONATE-MS consortium

Oh J, Smolders J, Buijs F, Federer-Gsponer J, Meyer zu Hörste G, t.kuehnel, Mamdani M, Perrone C, van Tulder K, Testa C, Elze MC, Pedotti R, Kaczmarek L, Sharma V, Tackenberg B, Bar-Or A, Wiendl H.

Neuroscience | Multiple Sclerosis

02:30 AM

Duration 120mins Barcelona, Spain

Real-World Patterns of Ocrelizumab and Other Disease-Modifying Therapy Utilization Before, During and After Pregnancy in Women with Multiple Sclerosis: A Retrospective Claims-Based Cohort Study

Houtchens, Maria K.; Miller, Alexandra; Sheinson, Danny; Xia, Zhiyu; Pasquarelli, Noemi; Muros, Erwan; Pineda, Elmor D

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

Sustained Serum Neurofilament Light Chain Reduction and Clinical Outcomes With Long-Term Ocrelizumab Treatment in OPERA I and ORATORIO Trials and Their Open-Label Extensions in Relapsing and Primary Progressive MS

Kuhle, Jens; Thanei, Gian; Benkert, Pascal; Bar-Or, Amit; Cross, Anne H.; Kappos, Ludwig; Leppert, David; Herman, Ann; Jia, Xiaoming; Raposo, Catarina; Hauser, Stephen L.

Neuroscience | Multiple Sclerosis

12:45 PM

Duration 120mins Barcelona, Spain

Maternal and infant pregnancy outcomes in women with MS who received ocrelizumab versus a comparator MS population: results of the Ocrelizumab Pregnancy Registry

Hellwig, Kerstin; Ferreira, Germano; Pacheco Duran, Gonzalo; Alves, Daniela; Pasquarelli, Noemi; Houtchens, Maria

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

MANUSCRIPT: long-term surveillance of ocrelizumab-treated patients with multiple sclerosis interim comparative safety analysis

Butzkueven, Helmut; Buttman, Mathias; Duran-Pacheco, Gonzalo Christian; El Azouzzi, Bouchra; Elberling, Frederik; Ferreira, Germano; Flavia Mouresan, Elena; Glaser, Anna; Hillert, Jan; Iaffaldano, Pietro; Lucisano, Giuseppe; Muros-Le Rouzic, Erwan; Rollot, Fabien; Trojano, Maria; Vukusic, Sandra; Zhu, Chao; Ziemssen, Tjalf; Magyari, Melinda

Neuroscience | Multiple Sclerosis

Duration 120mins Barcelona, Spain

Ocrelizumab subcutaneous: final analysis of the OCARINA II study

Newsome, Scott D; Goldstick, Lawrence; Selmaj, Krzysztof; Krzystanek, Eva; Zecevic, Dusanka; Clinch, Susanne; Giacobino, Caroline; Azmi, Jay; Figueiredo, Catarina; Centonze, Diego

Neuroscience | Multiple Sclerosis

Duration 10mins Lecture Hall 211

Humoral Responses and 1-Year Follow Up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding: Final Analysis of the Prospective, Multicentre, Open-Label, Phase IV Studies MINORE and SOPRANINO

Bove, Riley; Hellwig, Kerstin; Dobson, Ruth; Oreja-Guevara, Celia; Derfuss, Tobias; Shah, Anna; Graham, Edith L; McElrath, Thomas; Pietrasanta, Carlo; Maillart, Elisabeth; Jacobs, Dina; Kazlauskaite, Agne; Alves, Daniela; Raposo, Catarina; Craveiro, Licinio; Lin, Chien-Ju; Pasquarelli, Noemi; Vukusic, Sandra

Neuroscience | Multiple Sclerosis

01:15 PM

Duration 10mins Lecture Hall 211

Ocrelizumab Dose Selection for Treatment of Paediatric Relapsing-Remitting Multiple Sclerosis: Long-Term 96-Week Safety and Efficacy Results of the Phase II OPERETTA 1 Study

Waubant, Emmanuelle; Kotulska, Katarzyna; Valeriani, Massimiliano; Mar, Soe; Steinborn, Barbara; Schreiner, Teri; Filippi, Massimo; Mazurkiewicz-Beldzinska, Maria; Hennika, Tammy; Campos, Norodom; Lin, Chien-Ju; El-Azzouzi, Bouchra; Banwell, Brenda

Neuroscience | Multiple Sclerosis

07:26 AM

Duration 10mins Auditorium

Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension

Oh, Jiwon; Drulovic, Jelena; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Chen, Ying-Fang; Harp, Christoper; Sierzega, Malgorzata; Clayton, David; Ratchford, Jack; Goodyear, Alexandra; Bar-Or, Amit

Neuroscience | Multiple Sclerosis

08:35 AM

Duration 10mins Auditorium

Ocrelizumab vs Placebo in Primary Progressive MS: Efficacy and Safety Results of the Phase IIIb ORATORIO-HAND Study

Giovannoni, Gavin; Airas, Laura; Bove, Riley; Cutter, Gary; Hobart, Jeremy; Kuhle, Jens; Montalban, Xavier; Tur, Carmen; Wolinsky, Jerry S; Schneble, Hans-Martin; Baldinotti, Anna; Bonati, Ulrike; Giacobino, Caroline; Wang, Qing; Yang, Ke; Oh, Jiwon

Neuroscience | Multiple Sclerosis

08:45 AM

Duration 10mins Auditorium

Efficacy and Safety of a Body-Weight–Adjusted High Dose of Ocrelizumab vs Standard Dose in PPMS: Primary Results of the Phase IIIb GAVOTTE Study

Hauser, Stephen L.; Giovannoni, Gavin; Kappos, Ludwig; Oh, Jiwon; Bar-Or, Amit; Sormani, Maria Pia; Weber, Martin S.; Stoll, Sharon; Nicholas, Jacqueline A.; Nehrych, Tetyana; Bonek, Robert; Zecevic, Dusanka; Raposo, Catarina; Owen, Rebecca; Bonati, Ulrike; Madjar, Katrin; Wang, Qing; Raievska, Anastasiia; Schneble, Hans-Martin; Montalban, Xavier

Neuroscience | Multiple Sclerosis

08:55 AM

Duration 10mins Auditorium

Efficacy and Safety of Ocrelizumab Compared With Fingolimod in Paediatric Relapsing-Remitting MS: Results of the Phase III OPERETTA 2 Study

Banwell, Brenda; Kotulska, Katarzyna, Rostásy, Kevin; Deiva, Kumaran; Sato, Henry; Filippi, Massimo; Chitnis, Tanuja; Pia Sormani, Maria; Krupp, Lauren; Bar-Or, Amit; Evershed, Joanna; El Azzouzi, Bouchra; Wang, Qing; Lin, Chien-Ju; Hogea, Alexandra; Schneble, Hans-Martin; Manlius, Corinne; Waubant, Emmanuelle

Neuroscience | Multiple Sclerosis

Coming soon